You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Hyperlipoproteinemia Type I

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Hyperlipoproteinemia Type I, Hypertriglyceridemia Trial in Dallas (Orlistat)

Active, not recruiting
Has Results
  • Hyperlipoproteinemia Type I
  • Hypertriglyceridemia
  • Dallas, Texas
    UT Southwestern Medical Center 5323 Harry Hines Blvd
Jan 23, 2022

Familial Chylomicronemia Syndrome Trial (VSA001 injection, Placebo)

Not yet recruiting
  • Familial Chylomicronemia Syndrome
  • VSA001 injection
  • Placebo
  • (no location specified)
Jun 9, 2023

Lipoprotein Lipase Deficiency, Familial Hyperlipoproteinemia Type 1, Familial Hyperchylomicronemia Trial in Berlin

Active, not recruiting
  • Lipoprotein Lipase Deficiency
  • +2 more
  • Observational study
  • Berlin, Germany
    Interdisciplinary Metabolism Center, Lipid Out-Patient-Clinic, L
May 9, 2022

LDL Hyperlipoproteinemia, Low-Density-Lipoprotein-Type [LDL] Hyperlipoproteinemia, Triglyceride Storage Type I or II Disease

Not yet recruiting
  • LDL Hyperlipoproteinemia
  • +2 more
  • omega-3 fatty acids
  • Placebo
  • Novosibirsk, Novosibisk Region, Russian Federation
    Center of New Medical Technologies
Nov 30, 2023

Familial Chylomicronemia Trial (Volanesorsen)

No longer available
  • Familial Chylomicronemia
  • (no location specified)
Sep 10, 2021

Familial Chylomicronemia Syndrome Trial in Worldwide (Olezarsen)

Recruiting
  • Familial Chylomicronemia Syndrome
  • Huntington Beach, California
  • +4 more
Aug 4, 2022

Biomarker for Homozygous Familial Hypercholesterolemia (BioHoFH)

Active, not recruiting
  • Lipoprotein Lipase Deficiency
  • +2 more
    • Rostock, Germany
    • +3 more
    May 12, 2021

    Familial Chylomicronemia Syndrome Trial in Canada, Sweden, United States (Olezarsen)

    Recruiting
    • Familial Chylomicronemia Syndrome
    • Huntington Beach, California
    • +10 more
    Aug 4, 2022

    Type 1 Hyperlipoprotenemia Trial (Orlistat, Placebo)

    Not yet recruiting
    • Type 1 Hyperlipoprotenemia
    • (no location specified)
    Apr 14, 2023

    Familial Chylomicronemia Syndrome, Lipoprotein Lipase Deficiency, Hyperlipoproteinemia Type 1 Trial in Montréal

    Completed
    Has Results
    • Familial Chylomicronemia Syndrome
    • +2 more
    • Montréal, Quebec, Canada
      Investigative Site
    Dec 11, 2020

    Baby Detect : Genomic Newborn Screening

    Recruiting
    • Congenital Adrenal Hyperplasia
    • +126 more
      • Liege, Wallonia, Belgium
        CRMN, Hôpital La Citadelle
      Jan 24, 2023

      Familial Chylomicronemia Trial in Worldwide (ARO-APOC3, Placebo)

      Recruiting
      • Familial Chylomicronemia
      • Suwanee, Georgia
      • +18 more
      Aug 3, 2022

      Type 1 Hyperlipoproteinemia Trial in Dallas (SLx-4090 , Orlistat Placebo, Orlistat)

      Terminated
      Has Results
      • Type 1 Hyperlipoproteinemia
      • SLx-4090 placebo
      • +3 more
      • Dallas, Texas
      • +1 more
      Jul 26, 2021

      Familial Chylomicronemia Syndrome, Lipoprotein Lipase Deficiency, Hyperlipoproteinemia Type 1 Trial in Worldwide (Volanesorsen)

      Completed
      Has Results
      • Familial Chylomicronemia Syndrome
      • +2 more
      • Huntington Beach, California
      • +33 more
      Aug 3, 2021

      Homozygous Familial Hypercholesterolemia Trial in Xi'an (NGGT006)

      Not yet recruiting
      • Homozygous Familial Hypercholesterolemia
      • NGGT006
      • Xi'an, Shaanxi, China
        First Affiliated Hospital of Xian Jiaotong University
      Nov 5, 2023

      Familial Hypertriglyceridemia Trial (Heredity for cardiovascular disease, Heredity for pancreatitis, Heredity for type 2

      Active, not recruiting
      • Familial Hypertriglyceridemia
      • Heredity for cardiovascular disease
      • +3 more
      • (no location specified)
      Oct 23, 2023

      Hypertriglyceridemia, Familial Chylomicronemia Trial in Australia, Canada, New Zealand (ARO-APOC3, sterile normal saline (0.9%

      Completed
      • Hypertriglyceridemia
      • Familial Chylomicronemia
      • Camperdown, New South Wales, Australia
      • +9 more
      Mar 2, 2021

      Familial Hyperlipidemia Trial

      Not yet recruiting
      • Familial Hyperlipidemia
        • (no location specified)
        Apr 12, 2023

        Familial Hypercholesterolemia Trial in Russian Federation

        Recruiting
        • Familial Hypercholesterolemia
          • Chelyabinsk, Russian Federation
          • +4 more
          Apr 4, 2021

          Advanced Lipoproptein Profiling and Cardiovascular Risk

          Recruiting
          • Familial Hypercholesterolemia
          • Atherosclerosis
          • Additionnal blood samples
          • Paris, France
            Hôpital de la Pitié Salpêtrière
          Aug 2, 2022

          Familial Hypercholesterolemia Trial

          Not yet recruiting
          • Familial Hypercholesterolemia
            • (no location specified)
            Apr 11, 2023

            Hypertriglyceridemia, Familial Trial in Nanjing (GC304)

            Not yet recruiting
            • Hypertriglyceridemia, Familial
            • GC304
            • Nanjing, China
              Affiliated Jinling Hospital, Medical School, Nanjing University
            May 5, 2023

            Familial Hypercholesterolemia Trial in Philadelphia (Cascade screening)

            Enrolling by invitation
            • Familial Hypercholesterolemia
            • Cascade screening
            • Philadelphia, Pennsylvania
              University of Pennsylvania, Perelman School of Medicine
            Feb 27, 2023

            Cardiovascular Risk Markers in Familial Hypercholesterolemia

            Recruiting
            • Familial Hypercholesterolemia
              • Oslo, Norway
                Oslo University Hospital
              Oct 12, 2022

              Complex Regional Pain Syndrome Type I Trial (Mirror Therapy exercise)

              Completed
              • Complex Regional Pain Syndrome Type I
              • Mirror Therapy exercise
              • (no location specified)
              Oct 20, 2023